Sign in
4

Changes in Ownership

Bone Biologics Corp Filed Acc 0001209191-15-087442

Options or other derivatives

  • Chief Financial Officer acquired 705,620 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Walsh Deina H · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2015-12-28 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +239,825 239,825 D
2015-12-28 Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) +465,795 465,795 D
Loading xslF345X03/doc4.xml…